-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 15, Shandong Province announced the results of the selection of 49 nationally-sourced drug product regulations, with the largest drop of 96.
The national organization of centralized drug procurement started in 2019, and six batches have been carried out so far.
Large varieties of injections refresh low prices
Foreign companies show enthusiasm
The results of the proposed selection announced by the 49 national drug product regulations of Shandong show that the proposed prices of 36 drugs that are inquired about prices have been stable and have decreased compared with the prices of the original national organization’s centralized procurement to supply Shandong; the prices of 11 drugs proposed to be selected at competitive prices are relatively low.
Among them, the largest price drop was dexmedetomidine hydrochloride injection (2ml: 0.
The huge drop in dexmedetomidine hydrochloride injection is also a manifestation of its increasingly fierce market competition to a certain extent
TOP10 injections by the number of over-rated companies
(Source: Mi Nei Net)
Dexmedetomidine injections include dexmedetomidine hydrochloride injection and dexmedetomidine hydrochloride sodium chloride injection
In addition, the largest price reduction in Shandong’s renewal of the bid was pemetrexed disodium for injection (0.
Four typical models for renewal of bids
Prices rise or fall, the competition is still excited intense
On November 4, the National Medical Insurance Administration issued the "Notice on Doing a Good Job in Continuing Work after the Expiry of the National Organizational Drug Centralized Procurement Agreement", which pointed out that all national organizations should continue to carry out centralized procurement after the expiration of the drug centralized procurement agreement.
In the view of Geng Hongwu, general marketing consultant of Jointown Pharmaceutical Group, the renewed bidding of China National Acquisition Corporation is the most representative of Beijing, Shanghai, Guangdong, Hubei and other provinces (cities), forming four typical models, namely, Beijing’s two-way selection inquiry model, Shanghai's comprehensive evaluation bidding model, Guangdong's group bidding model and Hubei's double-envelope bidding model
Judging from the current actual situation in various places, industry insiders have summarized the following major characteristics of overseas bidding
Second, the winning price has risen and fallen from the previous round of renewal prices
Third, the process of renewing the bid is also a process of re-competition of enterprise products, and the market structure is reconstructed